CONNECTIVE TISSUE DISEASE-ASSOCIATED THROMBOCYTOPENIA
Clinical trials for CONNECTIVE TISSUE DISEASE-ASSOCIATED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CONNECTIVE TISSUE DISEASE-ASSOCIATED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CONNECTIVE TISSUE DISEASE-ASSOCIATED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cell therapy tested as potential reset for stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a single infusion of 'universal' CAR T-cells in adults with severe autoimmune diseases like lupus and scleroderma that have not improved with standard treatments. The therapy aims to target and remove harmful immune cells to potentially control t…
Matched conditions: CONNECTIVE TISSUE DISEASE-ASSOCIATED THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test 'Off-the-Shelf' cell therapy to reset immune system in devastating autoimmune diseases
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy called QT-019C for people with severe autoimmune diseases that have not improved with standard treatments. The therapy uses donated, 'universal' immune cells engineered to target and remove harmful immune cells. The mai…
Matched conditions: CONNECTIVE TISSUE DISEASE-ASSOCIATED THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC